ORGLIST: Drug Discovery & Development - eCheminfo Autumn meeting, program, CFP, bursary awards

Date view Thread view Subject view Author view Attachment view

From: Barry Hardy (barry.hardy$##$tiscalinet.ch)
Date: Tue Mar 27 2007 - 06:49:40 EDT


I enclose below our first announcement on the program for our
eCheminfo Autumn Community of Practice meeting on Drug Discovery &
Development which will be held at Bryn Mawr the week of October
15. Included are descriptions of programs, workshops and forums, a
CFP and information on Bursary Awards.

The conference program will cover Structure-based Drug Design,
chaired by Jose Duca (Schering- Plough), Fragment-based Drug
Discovery, chaired by Maria Kontoyianni (Crystax Pharmaceuticals),
Structural Biology, chaired by Max Cummings (Johnson & Johnson PR&D)
and Predictive ADME/Toxicology, chaired by Tony Hopfinger (University
of New Mexico College of Pharmacy).

A variety of workshops will be held throughout the meeting. The
approach will be hands-on using an IT classroom and a set of
workshops led by application scientists using leading drug discovery
software packages.

The following two forums will be held at the meeting:
* Virtual Screening & Docking - Comparative Methodology & Best Practice
* Forum & Workshop on International Cooperation in ADME/Tox

Early registration runs through end of June.

best regards
Barry Hardy
Community of Practice Manager
Douglas Connect
Switzerland
Tel: +41 61 851 0170

Latest Advances in Drug Discovery & Development
15-18 October 2007
Community of Practice Meeting, Autumn 2007
a joint InnovationWell and eCheminfo InterAction Meeting
Bryn Mawr College, Philadelphia
<http://www.echeminfo.com/COMTY_conferences>http://www.echeminfo.com/COMTY_conferences
(Last year's agenda is given at
<http://www.echeminfo.com/comty_conferenceprogram>http://www.echeminfo.com/comty_conferenceprogram)

eCheminfo Program
The program will consist of two primary components, seminar sessions
and workshops, accompanied by a significant amount of discussion and
networking activity. A focus of this meeting is to present and
discuss research involving methods and practical approaches which the
attendees will be able to take back to their labs and apply to their
projects. Last year's sessions were well attended and evaluated with
a mix of industry case-studies and applications, discussion of
methods and results and incorporation of the medicinal/synthetic
chemistry element with great emphasis on scientific discussions.

The seminar program will have four main conference sessions:

Structure-based Drug Design, chaired by Jose Duca (Schering-Plough)

Fragment-based Drug Discovery, chaired by Maria Kontoyianni (Crystax
Pharmaceuticals)

Structural Biology, chaired by Max Cummings (Johnson & Johnson PR&D)

Predictive ADME/Toxicology, chaired by Tony Hopfinger (University of
New Mexico College of Pharmacy)

Confirmed Invited Speakers for eCheminfo Program (Preliminary List)
Stephen Burley (SGX Pharmaceuticals), Georgia McGaughey (Merck),
Charles Lesburg (Schering-Plough), Woody Sherman (Schrodinger),
Daniel Cheney (Bristol Myers Squibb), Paul Labute (Chemical Computing
Group), Ajay Jain (UCSF), Alan Cheng (Amgen), Tony Hopfinger
(University of New Mexico), Anthony Klon (Pharmacopeia Drug
Discovery), Artem Cherkasov (University of British Columbia), Dennis
Pelletier (Pfizer), Chaohong Sun (Abbott), Xavier Barril (University
of Barcelona), Jose Duca (Schering-Plough), Terry Stouch

Workshops
A variety of workshops will be held throughout the meeting. The
approach will be hands-on using an IT classroom and a set of
workshops led by application scientists using leading drug discovery
software packages. Each workshop will be accompanied by
practitioner-led discussions of the methods worked on by the group.

Topics to be covered: Virtual Screening & Docking; Structure-based
Drug Design; Ligand Optimisation & Library Design; Structure Search,
Similarity and Property Estimation; Data Mining, Analysis &
Visualisation; Integration of Cheminformatics & Bioinformatics Tools
& Data; Latest advances in ADME & Predictive Toxicology;
Pharmacokinetics & Pharmacodynamics and Physiological-based Simulation.

Forums
The following two forums will be held during the meeting:
A. Mon Oct 15th - Virtual Screening & Docking - Comparative
Methodology & Best Practice
B. Thursday, Friday Oct 18th,19th - Forum & Workshop on International
Cooperation in ADME/Tox
(More Information on eCheminfo website.)

InnovationWell program
http://innovationwell.net/
In our initial community of practice meetings including our
InnovationWell meeting last October at Bryn Mawr, Philadelphia we
have discussed recent and coming developments of relevance to drug,
life science and healthcare product development, drug and patient
safety and translational medicine.

This year's InnovationWell program at Bryn Mawr will have themes
running throughout the meeting covering areas of innovation (systems
biology, toxicology, metabolomics, biomarkers, diagnostics, emerging
biotech & nanotech, knowledge management) and which will have a
second topic division by session in terms of therapeutic area
(diabetes, oncology, cardiology, anti-inflammatory, anti-viral). Each
session will include discussion leadership from a therapeutic
specialty providing a clinical perspective on the deployment and
integration of emerging areas of life science, diagnostics and
knowledge management technologies so as to progress Critical Path
goals in clinical development and safety.

Call for Contributed Talks & Posters to eCheminfo Program
We invite contributed papers from members of academic, government
research and commercial organizations on areas of new research and
innovation involving drug discovery research informatics. The work
presented should involve innovative new method development or
application to drug discovery problems and involving methods from
computational chemistry, computational biology, cheminformatics or
bioinformatics. Studies including experimental work in medicinal
chemistry, screening, experimental toxicology, pre-clinical
evaluation, lead optimisation and translational medicine are welcome.

Abstracts (300-500 words) should be submitted to echeminfo -[at]-
douglasconnect.com by 30 April 2007, and be accompanied by a short
biography of the presenting author (300-500 words). Abstracts
approved by the scientific organizing committee will be selected for
scheduling on the conference program and in meeting poster
sessions. Authors will be notified of acceptance by 31 May.

Bursary Awards for eCheminfo Program
Bursary Awards will be used to support the attendance of a selection
of academic young investigators at the meeting and
workshops. Applicants can be working in any area of research related
to drug discovery at the postdoctoral, graduate student and senior
undergraduate levels.

To apply for the bursary please send an email with a) your abstract
and biography (300-500 words each), b) your CV of 1-2 pages, c) a
short description of your interests and career motivations related to
drug discovery (300-500 words) to echeminfo -[at]- douglasconnect.com
by 30 April 2007. The recipients of the bursary awards will be
selected based on an evaluation of the quality and innovation of the
described research and the potential positive impact of attendance at
the meeting on their research and career progress. Recipients will be
notified of acceptance by 31 May.

Barry Hardy
Community of Practice Manager
Douglas Connect
Switzerland
Tel: +41 61 851 0170


_______________________________________________
ORGLIST - Organic Chemistry Mailing List
Website / Archive / FAQ: http://www.orglist.net
To post a message (TO EVERYBODY) send to everybody$##$orglist.net
To unsubscribe, send to everybody-request$##$orglist.net the message: unsubscribe your_orglist_password your_address


Date view Thread view Subject view Author view Attachment view

This archive was generated by hypermail 2.1.4 : Thu Feb 18 2010 - 16:51:51 EST